Interventional Oncology Devices – Market Insights – Europe (Supplemental)

The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing price competition, and ongoing cost constraints in the region.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019 to 2032.

Table of contents

Interventional Oncology Devices - Market Insights - Europe (Supplemental)

K Prasanna Bhat

K Prasanna Bhat is an associate healthcare research and data analyst on the Cardiovascular Medtech Insights team at Clarivate. Prasanna holds a Bachelor’s degree in Bachelor of Pharmacy and Master’s degree in Pharmaceutical administration from Manipal College of Pharmaceutical Sciences.

Contact sales Login to access report

Back to all Medtech Insights reports